Scripps Scientists Pioneer Vaccine To Combat Deadly “Zombie Drug” Xylazine

Chemical biologists at Scripps Research have developed a preliminary “proof-of-concept” vaccine, potentially paving the way for the first effective treatment for xylazine overdose in humans.
Xylazine, a sedative and pain reliever approved by the FDA for animals, causes severe side effects in humans. Recently, it has been illicitly mixed with opioids such as fentanyl and heroin, as well as cocaine. This has led to a significant increase in overdose fatalities.